233 related articles for article (PubMed ID: 33960196)
1. Quantitative Proteomic Approach for Discriminating Major Depressive Disorder and Bipolar Disorder by Multiple Reaction Monitoring-Mass Spectrometry.
Shin D; Rhee SJ; Lee J; Yeo I; Do M; Joo EJ; Jung HY; Roh S; Lee SH; Kim H; Bang M; Lee KY; Kwon JS; Ha K; Ahn YM; Kim Y
J Proteome Res; 2021 Jun; 20(6):3188-3203. PubMed ID: 33960196
[TBL] [Abstract][Full Text] [Related]
2. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a Nondepleted Plasma Multiprotein-Based Model for Discriminating Psychiatric Disorders Using Multiple Reaction Monitoring-Mass Spectrometry: Proof-of-Concept Study.
Shin D; Lee J; Kim Y; Park J; Shin D; Song Y; Joo EJ; Roh S; Lee KY; Oh S; Ahn YM; Rhee SJ; Kim Y
J Proteome Res; 2024 Jan; 23(1):329-343. PubMed ID: 38063806
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of metabolomics-based urinary biomarker models for recognizing major depression disorder and bipolar disorder.
Wang T; Yang J; Zhu Y; Niu N; Ding B; Wang P; Zhao H; Li N; Chao Y; Gao S; Dong X; Wang Z
J Affect Disord; 2024 Jul; 356():1-12. PubMed ID: 38548210
[TBL] [Abstract][Full Text] [Related]
5. Explainable machine-learning algorithms to differentiate bipolar disorder from major depressive disorder using self-reported symptoms, vital signs, and blood-based markers.
Zhu T; Liu X; Wang J; Kou R; Hu Y; Yuan M; Yuan C; Luo L; Zhang W
Comput Methods Programs Biomed; 2023 Oct; 240():107723. PubMed ID: 37480646
[TBL] [Abstract][Full Text] [Related]
6. Higher serum VGF protein levels discriminate bipolar depression from major depressive disorder.
Chen S; Jiang H; Hou Z; Yue Y; Zhang Y; Zhao F; Xu Z; Li Y; Mou X; Li L; Wang T; Zhao J; Han C; Sui Y; Wang M; Yang Z; Lu Y; Zhu Y; Li J; Shen X; Sun F; Chen Q; Yuan Y
J Neurosci Res; 2019 May; 97(5):597-606. PubMed ID: 30575991
[TBL] [Abstract][Full Text] [Related]
7. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
[TBL] [Abstract][Full Text] [Related]
8. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
[TBL] [Abstract][Full Text] [Related]
10. Differentiation between major depressive disorder and bipolar disorder by auditory steady-state responses.
Isomura S; Onitsuka T; Tsuchimoto R; Nakamura I; Hirano S; Oda Y; Oribe N; Hirano Y; Ueno T; Kanba S
J Affect Disord; 2016 Jan; 190():800-806. PubMed ID: 26625092
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder.
Idemoto K; Ishima T; Niitsu T; Hata T; Yoshida S; Hattori K; Horai T; Otsuka I; Yamamori H; Toda S; Kameno Y; Ota K; Oda Y; Kimura A; Hashimoto T; Mori N; Kikuchi M; Minabe Y; Hashimoto R; Hishimoto A; Nakagome K; Iyo M; Hashimoto K
J Psychiatr Res; 2021 Feb; 134():48-56. PubMed ID: 33360224
[TBL] [Abstract][Full Text] [Related]
12. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression.
Tomasik J; Harrison SJ; Rustogi N; Olmert T; Barton-Owen G; Han SYS; Cooper JD; Eljasz P; Farrag LP; Friend LV; Bell E; Cowell D; Bahn S
JAMA Psychiatry; 2024 Jan; 81(1):101-106. PubMed ID: 37878349
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project.
McIntyre RS; Soczynska JK; Cha DS; Woldeyohannes HO; Dale RS; Alsuwaidan MT; Gallaugher LA; Mansur RB; Muzina DJ; Carvalho A; Kennedy SH
J Affect Disord; 2015 Feb; 172():259-64. PubMed ID: 25451425
[TBL] [Abstract][Full Text] [Related]
15. Low BDNF levels in serum are associated with cognitive impairments in medication-naïve patients with current depressive episode in BD II and MDD.
Teng Z; Wang L; Li S; Tan Y; Qiu Y; Wu C; Jin K; Chen J; Huang J; Tang H; Xiang H; Wang B; Yuan H; Wu H
J Affect Disord; 2021 Oct; 293():90-96. PubMed ID: 34175594
[TBL] [Abstract][Full Text] [Related]
16. Serum uric acid as a predictor of bipolarity in individuals with a major depressive episode.
Dos Santos Oliveira PM; Santos V; Coroa M; Ribeiro J; Madeira N
Bipolar Disord; 2019 May; 21(3):235-243. PubMed ID: 30375143
[TBL] [Abstract][Full Text] [Related]
17. Mood spectrum symptoms during a major depressive episode: Differences between 145 patients with bipolar disorder and 155 patients with major depressive disorder. Arguments for a dimensional approach.
Cuomo A; Aguglia A; Aguglia E; Bolognesi S; Goracci A; Maina G; Mineo L; Rucci P; Sillari S; Fagiolini A
Bipolar Disord; 2020 Jun; 22(4):385-391. PubMed ID: 31630470
[TBL] [Abstract][Full Text] [Related]
18. Identifying the difference in time perception between major depressive disorder and bipolar depression through a temporal bisection task.
Liu P; Guo H; Ma R; Liu S; Wang X; Zhao K; Tan Y; Tan S; Yang F; Wang Z
PLoS One; 2022; 17(12):e0277076. PubMed ID: 36469514
[TBL] [Abstract][Full Text] [Related]
19. Ratio of mBDNF to proBDNF for Differential Diagnosis of Major Depressive Disorder and Bipolar Depression.
Zhao G; Zhang C; Chen J; Su Y; Zhou R; Wang F; Xia W; Huang J; Wang Z; Hu Y; Cao L; Guo X; Yuan C; Wang Y; Yi Z; Lu W; Wu Y; Wu Z; Hong W; Peng D; Fang Y
Mol Neurobiol; 2017 Sep; 54(7):5573-5582. PubMed ID: 27613282
[TBL] [Abstract][Full Text] [Related]
20. Undiagnosed bipolar disorder in patients treated for major depression in China.
Hu C; Xiang YT; Ungvari GS; Dickerson FB; Kilbourne AM; Si TM; Fang YR; Lu Z; Yang HC; Chiu HF; Lai KY; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Wang G
J Affect Disord; 2012 Oct; 140(2):181-6. PubMed ID: 22397888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
